Retrospective analysis to identify prognostic parameters for response to immune checkpoint blockade in non small cell lung cancer patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012643

Enrollment

200

Registered

2017-07-17

Start date

2016-12-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34

Interventions

Group 1: Non small cell lung cancer patients treated with immune checkpoint blockade since July 2015. General and disease specific details will be collected from patient files, radiological datasets a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Non small cell lung cancer patients treated with immune checkpoint blockade

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Restrospective correlation of clinical, laboratory, radiomorphological and histological paramaters before start of therapy with response in first restaging	—

Secondary

Measure	Time frame
Analysis of parameters stated above regarding progression free survival and overall survival	—

Countries

Germany

Contacts

Public ContactDominik Sonanini

Universitätsklinikum TübingenMedizinische Klinik II

dominik.sonanini@med.uni-tuebingen.de01735240281

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026